AMPrEP (Amsterdam PrEP)
Status:Ongoing
Phase:Demo Project
Principal Investigator(s):
Objective:To investigate the acceptability, feasibility and usability of an HIV infection prevention program for high-risk MSM through 2 different biomedical intervention strategies at the PHSA: daily Pre-exposure prophylaxis (PrEP) and intermittent Pre-exposure prophylaxis. Focuses on interest in using PrEP, compliance/adherence, risk compensation and cost-benefit analysis. The outcomes of the project will be used to inform the discussion around the inclusion of PrEP as a standard intervention for HIV prevention in the Netherlands.
Prevention Option(s):PrEP
Study Design:
Official Code:
AMPrEP (Amsterdam PrEP) (https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002569-32/NL)
Trial Sponsors:
Academic Medical Center, PHSA
Start Date
End Date
June 12, 2015
December 1, 2018
Enrollment:370
Age range:
18 Years ↔
any
Population:Cisgender Men, Gay and Bisexual Men Who Have Sex with Men